Literature DB >> 7805033

Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas.

D G Walker1, W Duan, E A Popovic, A H Kaye, F H Tomlinson, M Lavin.   

Abstract

The multiple tumor suppressor gene 1 (MTS1) located on chromosome 9p has recently been implicated as a candidate tumor suppressor gene in many different tumor types. Cytogenetic analysis and deletion mapping studies have revealed that deletion of chromosome 9p occurs in a significant number of primary human astrocytomas. Using multiplex PCR with primers for exon 2 of MTS1 and for D9S196 from chromosome 9q, we have analyzed 78 primary astrocytic tumors for the deletion of MTS1. After controlling for the contamination of tumor samples with normal cells, homozygous loss of MTS1 was found in 13 of 25 anaplastic astrocytomas (WHO grade III) and in 27 of 46 cases of glioblastomas (WHO grade IV) but in none of seven astrocytomas (WHO grade II). These data suggest that MTS1 is an important tumor suppressor gene in the malignant progression of astrocytomas.

Entities:  

Mesh:

Year:  1995        PMID: 7805033

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.

Authors:  H P Kourea; I Orlow; B W Scheithauer; C Cordon-Cardo; J M Woodruff
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin.

Authors:  L R De Vitis; A Tedde; F Vitelli; F Ammannati; P Mennonna; P Bono; B Grammatico; P Grammatico; P Radice; U Bigozzi; E Montali; L Papi
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

3.  P16 deletion and mutation analysis in human brain tumors.

Authors:  F G Barker; P Chen; F Furman; K D Aldape; M S Edwards; M A Israel
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

4.  Loss of p16INK4a results in increased glucocorticoid receptor activity during fibrosarcoma development.

Authors:  Ramon Roca; Robert M Kypta; Maria d M Vivanco
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

5.  CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.

Authors:  H Miettinen; J Kononen; P Sallinen; H Alho; P Helen; H Helin; H Kalimo; L Paljärvi; J Isola; H Haapasalo
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

6.  Exogenous expression of p16INK4a is associated with decrease in telomerase activity.

Authors:  H Sawa; H Kamada; T A Ohshima; A Noguchi; N Itoh; K Saruta; M Hara; I Saito
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

7.  What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia.

Authors:  Sarina Sulong; Abdul Aziz Mohamed Yusoff; Norafiza Zainuddin; Jafri Malin Abdullah; Jain George Pannatil; Hasnan Jaafar; Mohd Nizam Isa
Journal:  Malays J Med Sci       Date:  2004-01

Review 8.  Hepatocarcinogenesis in rodents and humans.

Authors:  T Kitagawa; K Miyasaka; H Kanda; H Yasui; O Hino
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations.

Authors:  S Xiao; A Renshaw; E S Cibas; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

10.  CDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients.

Authors:  M K Sibin; Dhananjaya I Bhat; Ch Lavanya; M Jeru Manoj; S Aakershita; G K Chetan
Journal:  Tumour Biol       Date:  2013-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.